ArticleDrug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy2024

Targeted dual degradation of HER2 and EGFR obliterates oncogenic signaling, overcomes therapy resistance, and inhibits metastatic lesions in HER2-positive breast cancer models.

Lu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.